Related Experiment Video
Updated: Jun 7, 2026

08:07
Analyzing DNA-Protein Interactions with Streptavidin-Based Biolayer Interferometry
Published on: January 17, 2025
Computational and mutagenesis studies of the streptavidin native dimer interface
1Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, NY 14260, USA.
Journal of Molecular Graphics & Modelling
|November 2, 2010
Summary
Streptavidin
Area of Science:
- Biochemistry
- Structural Biology
- Protein Engineering
Background:
- Streptavidin tetramerization is crucial for high-affinity biotin binding.
- The role of dimer formation in streptavidin's stability and function remains largely unexplored.
- Native dimers are essential prerequisites for streptavidin tetramer formation.
Purpose of the Study:
- To investigate the structural and functional impact of mutations at the streptavidin dimer interface.
- To understand how side chain interactions stabilize streptavidin subunit association.
- To explore the rational redesign of the streptavidin dimer interface.
Main Methods:
- Molecular dynamics (MD) simulations were employed to study interfacial mutations.
- Biochemical characterization, including denaturation and binding assays, was performed.
- Geometric parameterization, focusing on interface solvation, was used to interpret simulation data.
Main Results:
- Mutations altering polarity and side chain packing at the dimer interface were introduced.
- A geometric parameter (degree of solvation) effectively predicted dimer stability.
- Experimental data validated the predictive power of the geometric parameter for mutant stability.
Conclusions:
- Rational redesign of the streptavidin dimer interface is feasible.
- Interface solvation is a useful parameter for analyzing complex protein simulations.
- Understanding dimer stability provides insights into streptavidin's overall structure and function.
Related Concept Videos
Protein-Protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

